Receptos Company Profile (NASDAQ:RCPT)

About Receptos

Receptos logoReceptos, Inc. (Receptos) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics in immune disorders. Its product candidates span three disease areas. It is developing its lead asset, ozanimod (formerly RPC1063), as an oral therapy for the treatment of Relapsing Multiple Sclerosis (RMS) and Inflammatory Bowel Disease (IBD), which consists of Ulcerative Colitis (UC) and Crohn's Disease (CD). It is developing its second asset, RPC4046, for the treatment of an allergic/immune-mediated disorder, Eosinophilic Esophagitis (EoE), for which it has been granted Orphan drug designation. Its research efforts include a preclinical program developing oral, small molecule, positive allosteric modulators (PAMs) of the glucagon-like peptide-1 receptor (GLP-1R) for the treatment of Type 2 Diabetes.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: RCPT
  • CUSIP:
Key Metrics:
  • Previous Close: $231.96
  • 50 Day Moving Average: $226.05
  • 200 Day Moving Average: $174.22
  • 52-Week Range: $46.94 - $232.02
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -28.25
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to Receptos:

Analyst Ratings

Consensus Ratings for Receptos (NASDAQ:RCPT) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Receptos (NASDAQ:RCPT)
DateFirmActionRatingPrice TargetDetails
8/26/2015WedbushDowngradeOutperform -> Neutral$232.00View Rating Details
7/17/2015Evercore Partners Inc.Reiterated RatingBuy -> HoldView Rating Details
7/17/2015Evercore ISIDowngradeBuy -> HoldView Rating Details
7/15/2015NomuraDowngradeBuy -> Neutral$202.00 -> $232.00View Rating Details
7/15/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$232.00View Rating Details
2/19/2015Credit Suisse Group AGBoost Price TargetOutperform$125.00 -> $140.00View Rating Details
11/24/2014Leerink SwannBoost Price TargetOutperform$130.00 -> $186.00View Rating Details
10/28/2014Goldman Sachs Group Inc.Boost Price Target$132.00View Rating Details
(Data available from 10/24/2014 forward)


Earnings History for Receptos (NASDAQ:RCPT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/5/2015Q115($1.09)($1.29)$5.10 millionViewN/AView Earnings Details
3/3/2015Q414($1.19)($1.32)ViewN/AView Earnings Details
11/4/2014Q314($0.96)($1.19)$3.50 millionViewN/AView Earnings Details
8/12/2014Q214($0.85)($1.04)$1.28 million$1.10 millionViewN/AView Earnings Details
5/12/2014Q114($0.84)($1.01)$0.49 million$1.40 millionViewN/AView Earnings Details
3/5/2014($0.86)($0.86)ViewN/AView Earnings Details
10/30/2013Q313($0.61)($0.88)$1.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Receptos (NASDAQ:RCPT)
Current Year EPS Consensus Estimate: $-7.14 EPS
Next Year EPS Consensus Estimate: $-8.21 EPS


Dividend History for Receptos (NASDAQ:RCPT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Receptos (NASDAQ:RCPT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/16/2015S. Edward TorresDirectorSell220,000$178.99$39,377,800.00View SEC Filing  
2/23/2015S. Edward TorresDirectorSell47,906$128.20$6,141,549.20View SEC Filing  
11/11/2014Faheem HasnainCEOSell200,000$109.47$21,894,000.00View SEC Filing  
11/11/2014Sheila GujrathiInsiderSell30,000$108.99$3,269,700.00View SEC Filing  
11/10/2014Chrysa MineoSVPSell30,000$109.73$3,291,900.00View SEC Filing  
11/10/2014Faheem HasnainCEOSell136,795$109.69$15,005,043.55View SEC Filing  
11/10/2014Marcus F BoehmCTOSell40,454$109.91$4,446,299.14View SEC Filing  
9/23/2014S. Edward TorresDirectorSell100,000$61.36$6,136,000.00View SEC Filing  
9/22/2014S. Edward TorresDirectorSell14,318$63.08$903,179.44View SEC Filing  
9/22/2014Sheila GujrathiInsiderSell30,000$61.45$1,843,500.00View SEC Filing  
9/19/2014S. Edward TorresDirectorSell169,570$62.55$10,606,603.50View SEC Filing  
9/18/2014S. Edward TorresDirectorSell91,513$62.77$5,744,271.01View SEC Filing  
9/17/2014David A HinkleCAOSell2,000$64.82$129,640.00View SEC Filing  
9/17/2014S. Edward TorresDirectorSell38,917$63.67$2,477,845.39View SEC Filing  
9/16/2014Graham K CooperCFOSell50,000$61.30$3,065,000.00View SEC Filing  
9/2/2014David A HinkleCAOSell2,000$52.80$105,600.00View SEC Filing  
8/13/2014David A HinkleCAOSell3,000$42.69$128,070.00View SEC Filing  
8/13/2014S. Edward TorresDirectorSell200,000$43.24$8,648,000.00View SEC Filing  
5/29/2014Kristina BurowDirectorSell153,698$29.74$4,570,978.52View SEC Filing  
5/21/2014S. Edward TorresDirectorSell424,068$25.26$10,711,957.68View SEC Filing  
5/15/2014S. Edward TorresDirectorSell90,075$27.37$2,465,352.75View SEC Filing  
5/14/2014Kristina BurowDirectorSell45,381$29.66$1,346,000.46View SEC Filing  
1/3/2014William RastetterDirectorSell37,359$30.85$1,152,525.15View SEC Filing  
1/2/2014William RastetterDirectorSell27,581$30.29$835,428.49View SEC Filing  
12/6/2013Amir NashatDirectorSell170,000$26.70$4,539,000.00View SEC Filing  
12/5/2013William RastetterDirectorSell500,000$27.63$13,815,000.00View SEC Filing  
11/18/2013Ventures Fund 2007 Flagshipmajor shareholderSell230,787$24.75$5,711,978.25View SEC Filing  
11/15/2013Amir NashatDirectorSell169,315$24.96$4,226,102.40View SEC Filing  
5/14/2013Amir NashatDirectorBuy151,343$14.00$2,118,802.00View SEC Filing  
5/14/2013Ventures Fund 2007 L FlagshipMajor ShareholderBuy107,142$14.00$1,499,988.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Receptos (NASDAQ:RCPT)
News IconNew Analyst Ratings On Receptos, Inc. (NASDAQ:RCPT) - NewsDen (NASDAQ:RCPT) - October 21 at 10:32 AM
News IconReceptos, Inc. (NASDAQ:RCPT) Updated Broker Price Targets - The De Soto Edge (NASDAQ:RCPT) - October 12 at 12:26 PM
News IconLatest Analyst Ratings For Receptos, Inc. (NASDAQ:RCPT) - The De Soto Edge (NASDAQ:RCPT) - October 10 at 11:46 AM
News IconBroker Roundup For Receptos, Inc. (NASDAQ:RCPT) - The De Soto Edge (NASDAQ:RCPT) - October 6 at 12:34 PM
News IconTrading Update: Following Activity of Receptos, Inc. (NASDAQ:RCPT) Shares During the Current Session - Post News (NASDAQ:RCPT) - September 8 at 10:49 AM logoReceptos, Inc. (NASDAQ:RCPT) Updated Price Targets - FTSE ... - FTSE News (NASDAQ:RCPT) - August 4 at 7:32 PM
News IconReceptos, Inc. (NASDAQ:RCPT): Trading Session Stock Performance Report - Press Telegraph (NASDAQ:RCPT) - July 18 at 12:34 PM logoNext Weeks Broker Price Targets For Receptos, Inc. (NASDAQ:RCPT) - Fiscal Standard (NASDAQ:RCPT) - July 17 at 11:11 AM
News IconReceptos, Inc. (NASDAQ:RCPT) - Focus Stock Review - Engelwood Daily (NASDAQ:RCPT) - July 13 at 7:28 PM
News IconReceptos, Inc. (NASDAQ:RCPT) - Focus Stock Update - Engelwood Daily (NASDAQ:RCPT) - July 11 at 7:00 PM
News IconReceptos, Inc. (NASDAQ:RCPT): Eye on Company Share Performance - Press Telegraph (NASDAQ:RCPT) - July 5 at 6:47 PM
News IconShare Recap and Performance Review for: Receptos, Inc. (NASDAQ:RCPT) - Telanagana Press (NASDAQ:RCPT) - July 3 at 6:23 PM
News IconReceptos, Inc. (NASDAQ:RCPT): Stock Performance Review - Press Telegraph (NASDAQ:RCPT) - July 2 at 6:39 PM
News IconCompany Target Price Watch: Receptos, Inc. (NASDAQ:RCPT) - Telanagana Press (NASDAQ:RCPT) - June 30 at 7:21 PM logoNew Broker Ratings For Receptos, Inc. (NASDAQ:RCPT) - FTSE News (NASDAQ:RCPT) - June 29 at 9:51 AM
News IconReceptos, Inc. (NASDAQ:RCPT)View on Wall Street Analyst Ratings - Engelwood Daily (NASDAQ:RCPT) - June 29 at 9:51 AM
News IconReceptos, Inc. (NASDAQ:RCPT) Recent Performance and Company Stock Review - Engelwood Daily (NASDAQ:RCPT) - June 27 at 7:01 PM logoReceptos, Inc. (NASDAQ:RCPT) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:RCPT) - June 27 at 11:14 AM
News IconReceptos, Inc. (NASDAQ:RCPT): Update on Stock Performance - Press Telegraph (NASDAQ:RCPT) - June 25 at 6:30 PM
News IconReceptos, Inc. (NASDAQ:RCPT): Share Update and Performance Review - Press Telegraph (NASDAQ:RCPT) - June 23 at 7:40 PM logoStocks Gapping Up Today – KELYB, CERU, LOAN, CHKE, MEIP, CBK, ATEA - (NASDAQ:RCPT) - June 13 at 10:01 AM logoRECEPTOS INC. (NASDAQ:RCPT) Financial Condition Compared to S&P 500 - CML News (NASDAQ:RCPT) - June 8 at 7:34 PM
News IconSentiment Score Update: Receptos, Inc. (NASDAQ:RCPT) - HNN (NASDAQ:RCPT) - June 3 at 7:39 PM
News IconReceptos, Inc. (NASDAQ:RCPT): Rundown on Share Performance - HNN (NASDAQ:RCPT) - June 2 at 7:31 PM
News IconTarget Price Outlook on Receptos, Inc. (NASDAQ:RCPT) - HNN (NASDAQ:RCPT) - June 2 at 7:31 PM
News IconStock Sentiment Update:Receptos, Inc. (NASDAQ:RCPT) - HNN (NASDAQ:RCPT) - June 1 at 10:00 AM
News IconWatching Earnings for Receptos, Inc. (NASDAQ:RCPT) - HNN (NASDAQ:RCPT) - May 31 at 10:41 AM
News IconView on Earnings Receptos, Inc. (NASDAQ:RCPT) - HNN (NASDAQ:RCPT) - May 28 at 8:02 PM
News IconReceptos, Inc. (NASDAQ:RCPT): Share Performance Update - Wall Street Hints and News (NASDAQ:RCPT) - May 24 at 8:18 PM
News IconReceptos, Inc. (NASDAQ:RCPT) Stock Impact Update - Wall Street Hints and News (NASDAQ:RCPT) - May 23 at 1:23 PM
News IconReceptos, Inc. (NASDAQ:RCPT) Slapped with $N/A Target Price - Wall Street Hints and News (NASDAQ:RCPT) - May 23 at 1:23 PM
News IconAfter Last Week What Do Analysts Think Of Receptos, Inc. (NASDAQ:RCPT) - Share Trading News (NASDAQ:RCPT) - May 23 at 12:39 AM
News IconReceptos, Inc. (NASDAQ:RCPT): Stock Performance Review - Wall Street Hints and News (NASDAQ:RCPT) - May 12 at 9:07 PM
News IconReceptos, Inc. (NASDAQ:RCPT) Impact Report & Update - Wall Street Hints and News (NASDAQ:RCPT) - May 12 at 9:07 PM
News IconNext Weeks Broker Price Targets For Receptos, Inc. (NASDAQ:RCPT) - Share Trading News (NASDAQ:RCPT) - May 9 at 8:17 PM
News IconReceptos, Inc. (NASDAQ:RCPT) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:RCPT) - April 25 at 11:08 PM
News IconAnalyst 52-Week Target Update : Receptos, Inc. (NASDAQ:RCPT) - The Post (NASDAQ:RCPT) - April 22 at 3:40 AM logoSentiment Score Review :Receptos, Inc. (NASDAQ:RCPT) - CCH Daily News (NASDAQ:RCPT) - April 21 at 10:28 PM
News IconStreet Analyst Ratings on Receptos, Inc. (NASDAQ:RCPT) - News Tribune (NASDAQ:RCPT) - April 21 at 10:28 PM
News IconReceptos, Inc. (NASDAQ:RCPT) Company Earnings in Focus - Stock Caller (NASDAQ:RCPT) - April 18 at 10:36 PM
News IconSentiment Score Review :Receptos, Inc. (NASDAQ:RCPT) - Business Standard Tribune (NASDAQ:RCPT) - April 18 at 10:36 PM
News IconReceptos, Inc. (NASDAQ:RCPT) Ratings & Price Target Review - News Tribune (NASDAQ:RCPT) - April 17 at 9:23 PM
News IconReceptos, Inc. (NASDAQ:RCPT) Shares in Focus - News Tribune (NASDAQ:RCPT) - April 16 at 8:01 PM
News IconStock Review for: Receptos, Inc. (NASDAQ:RCPT) - Stock Caller (NASDAQ:RCPT) - April 16 at 8:01 PM
News IconTarget Price Check on Receptos, Inc. (NASDAQ:RCPT) - Business Standard Tribune (NASDAQ:RCPT) - April 16 at 8:01 PM
News IconReceptos, Inc. (NASDAQ:RCPT) Focus on Company Earnings - Stock Caller (NASDAQ:RCPT) - April 15 at 10:01 PM
News IconCheck on Impact Score :Receptos, Inc. (NASDAQ:RCPT) - Business Standard Tribune (NASDAQ:RCPT) - April 15 at 10:01 PM
News IconPrice Target Review for Receptos, Inc. (NASDAQ:RCPT) - Business Standard Tribune (NASDAQ:RCPT) - April 14 at 10:53 PM logoIs This a Potential $7 Billion Waste for Celgene Corporation? (NASDAQ:RCPT) - January 8 at 8:19 AM logoRECEPTOS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:RCPT) - July 30 at 6:12 AM


Receptos (NASDAQ:RCPT) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by Staff